{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:06:06Z","timestamp":1776755166503,"version":"3.51.2"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.bbr.2011.04.031","type":"journal-article","created":{"date-parts":[[2011,4,30]],"date-time":"2011-04-30T21:59:47Z","timestamp":1304200787000},"page":"125-134","source":"Crossref","is-referenced-by-count":86,"title":["Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice"],"prefix":"10.1016","volume":"223","author":[{"given":"Sudhir N.","family":"Umathe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyamshree S.S.","family":"Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishant S.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2011.04.031_bib0005","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0091-3057(95)00122-D","article-title":"5-HT1A and 5-HT2 receptors mediate hypo- and hyperthermic effects of tryptophan in pargyline-pretreated rats","volume":"52","author":"Abdel-Fattah","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2011.04.031_bib0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0031-9384(91)90050-X","article-title":"Gradient of alarm substance in the forced swimming test","volume":"49","author":"Abel","year":"1991","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bbr.2011.04.031_bib0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(09)60240-3","article-title":"Obsessive\u2013compulsive disorder","volume":"374","author":"Abramowitz","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2011.04.031_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.euroneuro.2010.06.007","article-title":"Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype","volume":"21","author":"Aso","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0025","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1471-4159.2009.06025.x","article-title":"Lack of CB1 receptor activity impairs serotonergic negative feedback","volume":"109","author":"Aso","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2011.04.031_bib0030","first-page":"399","article-title":"Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5 HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635","volume":"4","author":"Badgy","year":"2001","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0035","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1523\/JNEUROSCI.1636-07.2007","article-title":"Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex","volume":"27","author":"Bambico","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2011.04.031_bib0040","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.277.5329.1094","article-title":"Functional role of high-affinity anandamide transport, as revealed by selective inhibition","volume":"277","author":"Beltramo","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbr.2011.04.031_bib0045","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1523\/JNEUROSCI.0678-08.2008","article-title":"Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses","volume":"28","author":"Best","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2011.04.031_bib0050","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1038\/sj.npp.1301061","article-title":"Anxiolytic-like properties of the anandamide transport inhibitor AM404","volume":"31","author":"Bortolato","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2011.04.031_bib0055","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","article-title":"Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress","volume":"62","author":"Bortolato","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2011.04.031_bib0060","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.pnpbp.2009.08.017","article-title":"Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids","volume":"33","author":"Campos","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2011.04.031_bib0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble burying behaviour: involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0070","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s002130050518","article-title":"Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats","volume":"135","author":"Chaperon","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2011.04.031_bib0075","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","article-title":"The ascent of mouse: advances in modelling human depression and anxiety","volume":"4","author":"Cryan","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bbr.2011.04.031_bib0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0014-5793(00)02082-2","article-title":"Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity","volume":"483","author":"De Petrocellis","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bbr.2011.04.031_bib0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1037\/1064-1297.5.2.107","article-title":"Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression","volume":"5","author":"Detke","year":"1997","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0090","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbr.2011.04.031_bib0095","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1046\/j.0022-3042.2002.00797.x","article-title":"Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum","volume":"80","author":"Devlin","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2011.04.031_bib0100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00213-003-1611-y","article-title":"Anandamide inhibits the DOI-induced head-twitch response in mice","volume":"171","author":"Egashira","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2011.04.031_bib0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0278-5846(94)90023-X","article-title":"Serotonergic mechanisms in anxiety","volume":"18","author":"Eison","year":"1994","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2011.04.031_bib0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1054\/plef.2001.0360","article-title":"Endocannabinoids in the central nervous system\u2014an overview","volume":"66","author":"Fride","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.bbr.2011.04.031_bib0115","first-page":"1191","article-title":"Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice","volume":"33","author":"Gomes","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2011.04.031_bib0120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.brainresbull.2008.11.003","article-title":"Contrasting effects of acute and chronic treatment with imipramine and fluoxetine on inhibitory avoidance and escape responses in mice exposed to the elevated T-maze","volume":"78","author":"Gomes","year":"2009","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bbr.2011.04.031_bib0125","first-page":"24","article-title":"Analysis of the marble burying response, marbles serve to measure digging rather than evoke burying","volume":"6","author":"Gyertyan","year":"1995","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptor mediates anxiolytic effects: covergent genetic and pharmacological evidence with CB1-specific agents","volume":"15","author":"Haller","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0135","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuroscience.2007.02.021","article-title":"Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice","volume":"146","author":"H\u00e4ring","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2011.04.031_bib0140","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1079\/BJN2003942","article-title":"The cannabinoid system: a role in both the homeostatic and hedonic control of eating?","volume":"90","author":"Harrold","year":"2003","journal-title":"Br J Nutr"},{"key":"10.1016\/j.bbr.2011.04.031_bib0145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2011.04.031_bib0150","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbr.2011.04.031_bib0155","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-4522(01)00509-7","article-title":"Coexpression of cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain","volume":"109","author":"Hermann","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2011.04.031_bib0160","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","article-title":"Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment","volume":"106","author":"Hill","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2011.04.031_bib0165","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.euroneuro.2005.03.003","article-title":"Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test","volume":"15","author":"Hill","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0170","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbr.2008.06.010","article-title":"The cannabinoid CB1 receptor inverse agonist AM251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats","volume":"193","author":"Hodge","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2011.04.031_bib0175","first-page":"22","article-title":"Obsessive\u2013compulsive disorder in Tourette syndrome","volume":"99","author":"Hounie","year":"2006","journal-title":"Adv Neurol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0180","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.mp.4001376","article-title":"Upregulation of CB1 receptors and agonist-stimulated [35S] GTPgammaS binding in the prefrontal cortex of depressed suicide victims","volume":"9","author":"Hungund","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2011.04.031_bib0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1254\/jjp.68.65","article-title":"5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice","volume":"68","author":"Ichimaru","year":"1995","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0190","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.pnpbp.2005.11.006","article-title":"Current animal models of obsessive compulsive disorder: a critical review","volume":"30","author":"Joel","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2011.04.031_bib0195","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.bbr.2011.04.031_bib0200","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1124\/jpet.105.100792","article-title":"Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide","volume":"317","author":"La Rana","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.031_bib0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2007.09.022","article-title":"The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons","volume":"578","author":"Lau","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2008.07.032","article-title":"Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test","volume":"593","author":"Lisboa","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-4328(97)00162-9","article-title":"Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour","volume":"94","author":"Londei","year":"1998","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2011.04.031_bib0220","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/sj.npp.1300615","article-title":"Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens","volume":"30","author":"Marinelli","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2011.04.031_bib0225","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/j.1471-4159.2007.04961.x","article-title":"CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A\/C receptors","volume":"103","author":"Mato","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2011.04.031_bib0230","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/FBP.0b013e3282ee7b44","article-title":"Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect","volume":"18","author":"McLaughlin","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0235","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003495-199039010-00010","article-title":"Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive\u2013compulsive disorder and panic disorder","volume":"39","author":"McTavish","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.bbr.2011.04.031_bib0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0245","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/npp.2008.98","article-title":"Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels","volume":"34","author":"Micale","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2011.04.031_bib0250","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0028-3908(02)00021-7","article-title":"Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 NK1 receptor antagonists","volume":"42","author":"Millan","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2011.04.031_bib0255","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1440-1681.2007.04692.x","article-title":"Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models","volume":"34","author":"Mitchell","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette's syndrome with delta 9-tetrahydrocannabinol (THC): a randomized crossover trial","volume":"35","author":"Muller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.bbr.2011.04.031_bib0265","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/sleep\/26.8.943","article-title":"Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study","volume":"26","author":"Murillo-Rodriguez","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.bbr.2011.04.031_bib0270","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.07.015","article-title":"A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants","volume":"547","author":"Nicolas","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0275","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1476-5381.1991.tb12392.x","article-title":"Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents","volume":"104","author":"Njung\u2019e","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0280","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0091-3057(91)90590-X","article-title":"Evaluation of marble-burying behavior as a model of anxiety","volume":"38","author":"Njung\u2019e","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2011.04.031_bib0285","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1016\/S0924-977X(03)91877-3","article-title":"Chronic treatment with fluoxetine produced time related alterations in opioid, cannabinoid and tyrosine hydroxylase gene expression in selected regions of the rat brain","volume":"13","author":"Oliva","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0290","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4088\/JCP.v63n1204","article-title":"Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect","volume":"63","author":"Overbeek","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2011.04.031_bib0295","unstructured":"Overbury AL, Marsden CA, Kendall DA. Effect of modification of 5-HT metabolism on cannabinoid induced behaviour and receptor function. In: 13th Annual Symposium on the Cannabinoids, 2003, p. 98."},{"key":"10.1016\/j.bbr.2011.04.031_bib0300","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/clinchem\/40.2.288","article-title":"Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter","volume":"40","author":"Owens","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.bbr.2011.04.031_bib0305","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2005.09.009","article-title":"Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids","volume":"111","author":"Oz","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bbr.2011.04.031_bib0310","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.lfs.2004.10.025","article-title":"Inverse agonism and neutral antagonism at cannabinoid CB1 receptors","volume":"76","author":"Pertwee","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2011.04.031_bib0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","article-title":"Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)","volume":"12","author":"Piomelli","year":"2006","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.bbr.2011.04.031_bib0320","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.bbr.2011.04.031_bib0325","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pbb.2006.03.011","article-title":"Role of TRPV1 and cannabinoid receptors in AM404-evoked hypothermia in rats","volume":"83","author":"Rawls","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2011.04.031_bib0330","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bjp.0703850","article-title":"Structure\u2013activity relationship for the endogenous cannabinoid anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens","volume":"132","author":"Ross","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0335","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.bjp.0705467","article-title":"Anandamide and vanilloid TRPV1 receptors","volume":"140","author":"Ross","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.031_bib0340","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cercor\/bhm161","article-title":"Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex","volume":"18","author":"Rubino","year":"2008","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.bbr.2011.04.031_bib0345","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s002130050181","article-title":"Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?","volume":"129","author":"S\u00e1nchez","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2011.04.031_bib0350","doi-asserted-by":"crossref","DOI":"10.1016\/0024-3205(95)02319-4","article-title":"Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep\u2013waking cycle analysis","volume":"58","author":"Santucci","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2011.04.031_bib0355","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","article-title":"Modulation of transmitter release via presynaptic cannabinoid receptors","volume":"22","author":"Schlicker","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bbr.2011.04.031_bib0360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0166-4328(96)00066-6","article-title":"Serotonergic control of the organization of feeding and satiety","volume":"73","author":"Simansky","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2011.04.031_bib0365","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/jpet.104.073536","article-title":"GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent","volume":"312","author":"Slattery","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.031_bib0370","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0091-3057(97)00422-X","article-title":"Biphasic effects of anandamide","volume":"59","author":"Sulcova","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2011.04.031_bib0375","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.npep.2008.04.005","article-title":"Gonadotropin releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice","volume":"42","author":"Umathe","year":"2008","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bbr.2011.04.031_bib0380","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.pnpbp.2009.06.013","article-title":"Neurosteroids modulate compulsive and persistent behavior in rodents: Implications for obsessive\u2013compulsive disorder","volume":"33","author":"Umathe","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2011.04.031_bib0385","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643281100341X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643281100341X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T12:34:13Z","timestamp":1712406853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016643281100341X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S016643281100341X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2011.04.031","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}